Literature DB >> 18391788

Fibroblast growth factor regulation of neovascularization.

Masahiro Murakami1, Michael Simons.   

Abstract

PURPOSE OF REVIEW: Fibroblast growth factors are potent angiogenic inducers; however, their precise roles in angiogenesis have not been well understood. In this review, we will focus on specific roles played by fibroblast growth factors in neovascularization. RECENT
FINDINGS: Although fibroblast growth factors promote a strong angiogenic response, it has been suggested that FGF-induced angiogenesis requires activation of the vascular endothelial growth factor system. Recent findings have endorsed the view of indirect contribution of fibroblast growth factor signaling to vascular development. A study using embryoid bodies demonstrated a nonimmediate role played by fibrobalst growth factor receptor 1 in vasculogenesis as vascular endothelial growth factor supplementation was sufficient to promote vascular development in Fgfr1-/- embryoid bodies. Moreover, another line of evidence indicated that myocardial fibroblast growth factor signaling is essential for mouse coronary development. The key role of fibroblast growth factor signaling in this process is Hedgehog activation, which induces vascular endothelial growth factor expression and formation of the coronary vasculature. In addition to vascular endothelial growth factor interaction, fibroblast growth factors can control neovascularization by influencing other growth factors and chemokines such as platelet-derived growth factor, hepatocyte growth factor and monocyte chemoattractant protein-1, contributing to development of mature vessels and collateral arteries.
SUMMARY: Although fibroblast growth factors are potent angiogenic factors, they may indirectly control neovascularization in concert with other growth factors. Thus, the unique role played by fibroblast growth factors might be organization of various angiogenic pathways and coordination of cell-cell interactions in this process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391788      PMCID: PMC2745288          DOI: 10.1097/MOH.0b013e3282f97d98

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  70 in total

Review 1.  Growth factor-induced therapeutic angiogenesis in the heart: protein therapy.

Authors:  Brian H Annex; Michael Simons
Journal:  Cardiovasc Res       Date:  2005-02-15       Impact factor: 10.787

Review 2.  Functions and regulations of fibroblast growth factor signaling during embryonic development.

Authors:  Bernard Thisse; Christine Thisse
Journal:  Dev Biol       Date:  2005-10-10       Impact factor: 3.582

3.  N-cadherin deficiency impairs pericyte recruitment, and not endothelial differentiation or sprouting, in embryonic stem cell-derived angiogenesis.

Authors:  Emmanuelle Tillet; Daniel Vittet; Olivier Féraud; Robert Moore; Rolf Kemler; Philippe Huber
Journal:  Exp Cell Res       Date:  2005-10-03       Impact factor: 3.905

4.  VEGF gene delivery to muscle: potential role for vasculogenesis in adults.

Authors:  M L Springer; A S Chen; P E Kraft; M Bednarski; H M Blau
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

Review 5.  Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.

Authors:  Marco Presta; Patrizia Dell'Era; Stefania Mitola; Emanuela Moroni; Roberto Ronca; Marco Rusnati
Journal:  Cytokine Growth Factor Rev       Date:  2005-02-02       Impact factor: 7.638

6.  VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling.

Authors:  Mitsunobu R Kano; Yasuyuki Morishita; Caname Iwata; Shigeru Iwasaka; Tetsuro Watabe; Yasuyoshi Ouchi; Kohei Miyazono; Keiji Miyazawa
Journal:  J Cell Sci       Date:  2005-08-15       Impact factor: 5.285

Review 7.  The Fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease.

Authors:  Nobuyuki Itoh
Journal:  Biol Pharm Bull       Date:  2007-10       Impact factor: 2.233

8.  Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis.

Authors:  Lars Johan Nissen; Renhai Cao; Eva-Maria Hedlund; Zongwei Wang; Xing Zhao; Daniel Wetterskog; Keiko Funa; Ebba Bråkenhielm; Yihai Cao
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung.

Authors:  M Weinstein; X Xu; K Ohyama; C X Deng
Journal:  Development       Date:  1998-09       Impact factor: 6.868

10.  Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis.

Authors:  G Seghezzi; S Patel; C J Ren; A Gualandris; G Pintucci; E S Robbins; R L Shapiro; A C Galloway; D B Rifkin; P Mignatti
Journal:  J Cell Biol       Date:  1998-06-29       Impact factor: 10.539

View more
  107 in total

1.  FGF-dependent regulation of VEGF receptor 2 expression in mice.

Authors:  Masahiro Murakami; Loc T Nguyen; Kunihiko Hatanaka; William Schachterle; Pei-Yu Chen; Zhen W Zhuang; Brian L Black; Michael Simons
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Integration of repulsive guidance cues generates avascular zones that shape mammalian blood vessels.

Authors:  Stryder M Meadows; Peter J Fletcher; Carlos Moran; Ke Xu; Gera Neufeld; Sophie Chauvet; Fanny Mann; Paul A Krieg; Ondine Cleaver
Journal:  Circ Res       Date:  2011-11-10       Impact factor: 17.367

3.  Angiomotin-like2 gene (amotl2) is required for migration and proliferation of endothelial cells during angiogenesis.

Authors:  Yeqi Wang; Zhiqiang Li; Pengfei Xu; Lei Huang; Jingyuan Tong; Huizhe Huang; Anming Meng
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

Review 4.  Emerging techniques to treat corneal neovascularisation.

Authors:  J Menzel-Severing
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

Review 5.  Wound healing fibroblasts modulate corneal angiogenic privilege: interplay of basic fibroblast growth factor and matrix metalloproteinases in corneal angiogenesis.

Authors:  Jin-Hong Chang; Kyu Yeon Han; Dimitri T Azar
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

Review 6.  Strategies for organ level tissue engineering.

Authors:  Kristine C Rustad; Michael Sorkin; Benjamin Levi; Michael T Longaker; Geoffrey C Gurtner
Journal:  Organogenesis       Date:  2010 Jul-Sep       Impact factor: 2.500

7.  Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells.

Authors:  Matthew J Frontini; Zengxuan Nong; Robert Gros; Maria Drangova; Caroline O'Neil; Mona N Rahman; Oula Akawi; Hao Yin; Christopher G Ellis; J Geoffrey Pickering
Journal:  Nat Biotechnol       Date:  2011-04-17       Impact factor: 54.908

Review 8.  Controlled protein delivery in the generation of microvascular networks.

Authors:  Jillian W Andrejecsk; William G Chang; Jordan S Pober; W Mark Saltzman
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

Review 9.  Cardiac fibroblast: the renaissance cell.

Authors:  Colby A Souders; Stephanie L K Bowers; Troy A Baudino
Journal:  Circ Res       Date:  2009-12-04       Impact factor: 17.367

10.  Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.

Authors:  Veronica C Ardi; Philippe E Van den Steen; Ghislain Opdenakker; Bernhard Schweighofer; Elena I Deryugina; James P Quigley
Journal:  J Biol Chem       Date:  2009-07-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.